Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics
about
Mechanisms linking red blood cell disorders and cardiovascular diseasesCoagulation activation in sickle cell trait: an exploratory studyCoagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathySickle cell disease is associated with iron mediated hypercoagulability.The trials and hopes for drug development in sickle cell disease.Clinically-oriented proteomic investigation of sickle cell disease: Opportunities and challenges.Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sicklIncreased Level of Factor VIII and Physiological Inhibitors of Coagulation in Patients with Sickle Cell Disease.Protein Z and Endothelin-1 genetic polymorphisms in pediatric Egyptian sickle cell disease patients.Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.Computational imaging analysis of fibrin matrices with the inclusion of erythrocytes from homozygous SS blood reveals agglomerated and amorphous structures.The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care
P2860
Q35091967-BB462182-51B1-4934-AFEB-32DFDBB15D7CQ36661960-98F23062-668E-4C0B-9F97-DE1F7838535EQ37033939-8318A838-A20E-40F4-A929-A994D73C9C1AQ37715448-6E3C203A-1F11-4A1D-9793-81816CA70AC9Q38386253-8DCAEA83-7824-4DA8-AA54-45EE1751B024Q38540335-34F37A47-2479-49B5-A142-62491DE6FEEAQ38837694-DC877429-CB43-47B3-92BD-F07F84F0238AQ46176953-9CBA990E-0E50-4722-B97B-624B9C6DC896Q46240026-56568A12-6734-4D24-ACC7-2FAAC12C4B79Q46688106-5EA14CF4-2A95-4735-9463-63B66E9E58ACQ48361831-826C9493-9F9E-4B1C-867E-5B968579CB6EQ50580182-57A5F07B-32D8-4450-904F-6550F9A89575Q58805360-9F6994D4-385C-45DD-AE07-3070ED3A725A
P2860
Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the hemostatic system ...... ogy and potential therapeutics
@en
Role of the hemostatic system ...... gy and potential therapeutics.
@nl
type
label
Role of the hemostatic system ...... ogy and potential therapeutics
@en
Role of the hemostatic system ...... gy and potential therapeutics.
@nl
prefLabel
Role of the hemostatic system ...... ogy and potential therapeutics
@en
Role of the hemostatic system ...... gy and potential therapeutics.
@nl
P2860
P1476
Role of the hemostatic system ...... ogy and potential therapeutics
@en
P2093
P2860
P304
P356
10.1016/J.HOC.2013.11.011
P50
P577
2014-01-18T00:00:00Z